Harley-Davidson is synonymous with power, heritage, and the spirit of freedom on two wheels. With over a century of legendary ...

He started well on Sunday and was sixth for a while, but after a few laps he turned into something of a road block with fading grip, not helped by a loose fairing that he had to manually hold in ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...

The Falcon 9 will deploy a payload of 21 Starlink internet satellites, which are packed inside the fairing atop the 230-foot rocket. No Central Florida sonic booms are expected. After soaring ...

Credit: Elena Vafina via Getty Images. Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ farnesoid X receptor (FXR) agonist ...

“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will provide an ...

Organovo Holdings, Inc. announced that it will be acquired by Eli Lilly and Company, which includes Organovo's FXR program and its lead asset, FXR314, aimed at treating inflammatory bowel disease ...

Eli Lil­ly is buy­ing Organo­vo’s far­ne­soid X re­cep­tor (FXR) ag­o­nist pro­gram, which in­cludes a drug in Phase 2 de­vel­op­ment for ul­cer­a­tive col­i­tis and meta­bol ...

SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotech firm specializing in 3D human tissue models, has reached an agreement to sell its FXR program, including the lead asset FXR314 ...

Organovo (ONVO) Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314. Under this transaction, Organovo will receive an ...

“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will ...